PA
EVH icon

Parallel Advisors’s Evolent Health EVH Stock Holding History

Parallel Advisors’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.5K Buy
3,043
+1,355
+80% +$5.2K ﹤0.01% 2712
2026
Q1 		$3.85K Buy
1,688
+493
+41% +$1.56K ﹤0.01% 3131
2025
Q4 		$4.78K Sell
1,195
-2,200
-65% -$12.2K ﹤0.01% 2860
2025
Q3 		$28.7K Sell
3,395
-92
-3% -$893 ﹤0.01% 2077
2025
Q2 		$39.3K Buy
3,487
+1,577
+83% +$14.5K ﹤0.01% 1861
2025
Q1 		$18.1K Buy
1,910
+1,185
+163% +$12K ﹤0.01% 2191
2024
Q4 		$8.16K Buy
725
+40
+6% +$703 ﹤0.01% 2480
2024
Q3 		$19.4K Sell
685
-9
-1% -$232 ﹤0.01% 2116
2024
Q2 		$13.3K Buy
694
+179
+35% +$4.57K ﹤0.01% 2201
2024
Q1 		$16.9K Sell
515
-16
-3% -$511 ﹤0.01% 2066
2023
Q4 		$17.5K Buy
531
+515
+3,219% +$14.6K ﹤0.01% 2018
2023
Q3 		$436 Sell
16
-6
-27% -$167 ﹤0.01% 3130
2023
Q2 		$667 Sell
22
-17
-44% -$550 ﹤0.01% 3035
2023
Q1 		$1.27K Sell
39
-74
-65% -$2.34K ﹤0.01% 2900
2022
Q4 		$3.17K Buy
113
+75
+197% +$2.15K ﹤0.01% 2504
2022
Q3 		$1K Sell
38
-18
-32% -$634 ﹤0.01% 2894
2022
Q2 		$2K Buy
56
+19
+51% +$554 ﹤0.01% 2565
2022
Q1 		$1K Sell
37
-51
-58% -$1.33K ﹤0.01% 2732
2021
Q4 		$2K Hold
88
– – ﹤0.01% 2685
2021
Q3 		$3K Hold
88
– – ﹤0.01% 2557
2021
Q2 		$2K Buy
88
+51
+138% +$1.02K ﹤0.01% 2547
2021
Q1 		$1K Buy
+37
New +$704 ﹤0.01% 2607
2020
Q2 		– Sell
-156
Closed – – 2516
2020
Q1 		$0 Sell
156
-224
-59% -$2K ﹤0.01% 2450
2019
Q4 		$3K Hold
380
– – ﹤0.01% 2096
2019
Q3 		$3K Buy
+380
New +$2.73K ﹤0.01% 2047
2019
Q1 		– Sell
-23
Closed – – 2311
2018
Q4 		$0 Buy
+23
New +$532 ﹤0.01% 2157

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Parallel Advisors's EVH Position: Q2 2026 in Review

Parallel Advisors increased its Evolent Health (EVH) stake by 80% in Q2 2026, buying an estimated $5.2K and bringing the position to 3,043 shares worth $16.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2712.

Parallel Advisors first reported a position in EVH in Q4 2018 and has held it in 26 quarters since. The position peaked at $39.3K in Q2 2025. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Parallel Advisors held 3,043 shares of Evolent Health worth $16.5K as of Q2 2026.
  • Parallel Advisors bought 1,355 Evolent Health shares in Q2 2026, an estimated $5.2K.
  • Evolent Health made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2712 holding.
  • Parallel Advisors first reported a position in Evolent Health in Q4 2018 and has held it in 26 quarters since.
  • Parallel Advisors's Evolent Health position peaked at $39.3K in Q2 2025.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.